Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Epilepsy

  Free Subscription


Articles published in Dev Med Child Neurol

Retrieve available abstracts of 110 articles:
HTML format



Single Articles


    July 2021
  1. NIU X, Yang Y, Chen Y, Cheng M, et al
    Genotype-phenotype correlation of CACNA1A variants in children with epilepsy.
    Dev Med Child Neurol. 2021 Jul 15. doi: 10.1111/dmcn.14985.
    PubMed     Abstract available


  2. CARVILL GL, Jansen S, Lacroix A, Zemel M, et al
    Genetic convergence of developmental and epileptic encephalopathies and intellectual disability.
    Dev Med Child Neurol. 2021 Jul 11. doi: 10.1111/dmcn.14989.
    PubMed     Abstract available


  3. BERG AT, Coffman K, Gaebler-Spira D
    Dysautonomia and functional impairment in rare developmental and epileptic encephalopathies: the other nervous system.
    Dev Med Child Neurol. 2021 Jul 11. doi: 10.1111/dmcn.14990.
    PubMed     Abstract available


    June 2021
  4. BYRNE S, Enright N, Delanty N
    Precision therapy in the genetic epilepsies of childhood.
    Dev Med Child Neurol. 2021 Jun 4. doi: 10.1111/dmcn.14929.
    PubMed     Abstract available


    May 2021
  5. NEWTON CR
    Epidemiology of status epilepticus in children.
    Dev Med Child Neurol. 2021 May 27. doi: 10.1111/dmcn.14946.
    PubMed    


    April 2021
  6. MITCHELL C, Chatterton Dickson L, Ramsay A, Mesalles-Naranjo O, et al
    Epidemiology and outcome of status epilepticus in children: a Scottish population cohort study.
    Dev Med Child Neurol. 2021 Apr 30. doi: 10.1111/dmcn.14900.
    PubMed     Abstract available


  7. PATRICK ENGKASAN J
    Does rapid withdrawal of antiseizure medication increase risk of seizure recurrence in epilepsy? A Cochrane Review summary with commentary.
    Dev Med Child Neurol. 2021 Apr 26. doi: 10.1111/dmcn.14906.
    PubMed    


    March 2021
  8. JONSSON U, Eek MN, Sunnerhagen KS, Himmelmann K, et al
    Changes in walking ability, intellectual disability, and epilepsy in adults with cerebral palsy over 50 years: a population-based follow-up study.
    Dev Med Child Neurol. 2021 Mar 27. doi: 10.1111/dmcn.14871.
    PubMed     Abstract available


    February 2021
  9. LIGUORI S
    Is sulthiame effective and tolerated as add-on therapy for infants with epilepsy? A Cochrane Review summary with commentary.
    Dev Med Child Neurol. 2021 Feb 18. doi: 10.1111/dmcn.14848.
    PubMed    


  10. GOGOU M, Cross JH
    Fenfluramine as antiseizure medication for epilepsy.
    Dev Med Child Neurol. 2021 Feb 9. doi: 10.1111/dmcn.14822.
    PubMed     Abstract available


  11. AHMAD FAUZI A, Patrick Engkasan J
    What are the effects of intravenous immunoglobulins on seizures and quality of life of people with epilepsy? A Cochrane Review summary with commentary.
    Dev Med Child Neurol. 2021 Feb 8. doi: 10.1111/dmcn.14835.
    PubMed    


  12. LAGAE L
    Cognitive outcome in drug-resistant childhood epilepsy.
    Dev Med Child Neurol. 2021 Feb 4. doi: 10.1111/dmcn.14832.
    PubMed    


    January 2021
  13. PUKA K, Smith ML
    Long-term outcomes of children with drug-resistant epilepsy across multiple cognitive domains.
    Dev Med Child Neurol. 2021 Jan 26. doi: 10.1111/dmcn.14815.
    PubMed     Abstract available


    December 2020
  14. ROMANO C, Giacchi V, Mauceri L, Pavone P, et al
    Neurodevelopmental outcomes of neonatal non-epileptic paroxysmal events: a prospective study.
    Dev Med Child Neurol. 2020 Dec 18. doi: 10.1111/dmcn.14784.
    PubMed     Abstract available


  15. JAHAN I, Al Imam MH, Karim T, Muhit M, et al
    Epidemiology of cerebral palsy in Sumba Island, Indonesia.
    Dev Med Child Neurol. 2020;62:1414-1422.
    PubMed     Abstract available


  16. SALAH L, Chabrier S, Thebault G, Kossorotoff M, et al
    Parental and professional opinion regarding outcome after neonatal stroke.
    Dev Med Child Neurol. 2020;62:1450-1451.
    PubMed    


    November 2020
  17. MEWASINGH LD, Chin RFM, Scott RC
    Current understanding of febrile seizures and their long-term outcomes.
    Dev Med Child Neurol. 2020;62:1245-1249.
    PubMed     Abstract available


    October 2020
  18. GEENEN KR, Patel S, Thiele EA
    Sunflower syndrome: a poorly understood photosensitive epilepsy.
    Dev Med Child Neurol. 2020 Oct 31. doi: 10.1111/dmcn.14723.
    PubMed     Abstract available


    August 2020
  19. ARMAN S
    What are the effects of ketogenic diets on drug-resistant epilepsy? A Cochrane Review summary with commentary.
    Dev Med Child Neurol. 2020 Aug 18. doi: 10.1111/dmcn.14643.
    PubMed    


  20. FONSECA WALD ELA, Debeij-Van Hall MHJA, De Jong E, Aldenkamp AP, et al
    Neurocognitive and behavioural profile in Panayiotopoulos syndrome.
    Dev Med Child Neurol. 2020;62:985-992.
    PubMed     Abstract available


  21. WILSON SJ
    Rethinking neurobehavioral comorbidity in Panayiotopoulos syndrome.
    Dev Med Child Neurol. 2020;62:893.
    PubMed    


    July 2020
  22. YANG Y, Xiangwei W, Zhang X, Xiao J, et al
    Phenotypic spectrum of patients with GABRB2 variants: from mild febrile seizures to severe epileptic encephalopathy.
    Dev Med Child Neurol. 2020 Jul 20. doi: 10.1111/dmcn.14614.
    PubMed     Abstract available



  23. Phenotypic spectrum of patients with GABRB2 variants: from mild febrile seizures to severe epileptic encephalopathy: GABRB2.
    Dev Med Child Neurol. 2020 Jul 7. doi: 10.1111/dmcn.14618.
    PubMed    


  24. UCHITEL J, Abdelnour E, Boggs A, Prange L, et al
    Social impairments in alternating hemiplegia of childhood.
    Dev Med Child Neurol. 2020;62:820-826.
    PubMed     Abstract available


  25. TAIRA R, Inoue H, Sawano T, Fujiyoshi J, et al
    Management of apnea in infants with trisomy 18.
    Dev Med Child Neurol. 2020;62:874-878.
    PubMed     Abstract available


    June 2020
  26. LIGUORI S
    Is topiramate effective and tolerated in young people with juvenile myoclonic epilepsy? A Cochrane Review summary with commentary.
    Dev Med Child Neurol. 2020 Jun 17. doi: 10.1111/dmcn.14598.
    PubMed    


  27. VEZYROGLOU A, Varadkar S, Bast T, Hirsch E, et al
    Focal epilepsy in SCN1A-mutation carrying patients: is there a role for epilepsy surgery?
    Dev Med Child Neurol. 2020 Jun 15. doi: 10.1111/dmcn.14588.
    PubMed     Abstract available


  28. GIMIGLIANO F
    Is clobazam monotherapy effective and safe in people with focal or generalized seizures? A Cochrane Review summary with commentary.
    Dev Med Child Neurol. 2020;62:670-672.
    PubMed    


    May 2020
  29. LEGRIEL S
    Hypothermia as an adjuvant treatment in paediatric refractory or super-refractory status epilepticus.
    Dev Med Child Neurol. 2020 May 15. doi: 10.1111/dmcn.14562.
    PubMed     Abstract available


  30. SPECCHIO N, Pietrafusa N
    New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome.
    Dev Med Child Neurol. 2020 May 5. doi: 10.1111/dmcn.14553.
    PubMed     Abstract available


  31. ORAL A
    How effective are self-management interventions for children with epilepsy? A Cochrane Review summary with commentary.
    Dev Med Child Neurol. 2020;62:551-553.
    PubMed    


  32. KELLEY SA
    Corticosteroids and ACTH for infantile spasms: are we closer to equipoise?
    Dev Med Child Neurol. 2020;62:540-541.
    PubMed    


  33. KOOT HM
    Quality of life in children: the use of parent reports.
    Dev Med Child Neurol. 2020;62:545-546.
    PubMed    


  34. LUX A
    The effectiveness of felbamate for drug-resistant infantile spasms.
    Dev Med Child Neurol. 2020;62:541-542.
    PubMed    


  35. LI S, Zhong X, Hong S, Li T, et al
    Prednisolone/prednisone as adrenocorticotropic hormone alternative for infantile spasms: a meta-analysis of randomized controlled trials.
    Dev Med Child Neurol. 2020;62:575-580.
    PubMed     Abstract available


  36. DOZIERES-PUYRAVEL B, Nasser H, Bellavoine V, Ilea A, et al
    Felbamate for infantile spasms syndrome resistant to first-line treatments.
    Dev Med Child Neurol. 2020;62:581-586.
    PubMed     Abstract available


    March 2020
  37. BRUNKLAUS A, Lal D
    Sodium channel epilepsies and neurodevelopmental disorders: from disease mechanisms to clinical application.
    Dev Med Child Neurol. 2020 Mar 30. doi: 10.1111/dmcn.14519.
    PubMed     Abstract available


  38. SPEECHLEY KN
    Fostering research pathways to positive long-term outcomes for childhood-onset epilepsy.
    Dev Med Child Neurol. 2020 Mar 7. doi: 10.1111/dmcn.14514.
    PubMed    


    February 2020
  39. BALESTRINI S, Sander JW
    Transcranial magnetic stimulation as a biomarker of treatment response in children with epilepsy.
    Dev Med Child Neurol. 2020 Feb 24. doi: 10.1111/dmcn.14496.
    PubMed    


  40. ANDREASSON AC, Sigurdsson GV, Pegenius G, Thordstein M, et al
    Cortical excitability measured with transcranial magnetic stimulation in children with epilepsy before and after antiepileptic drugs.
    Dev Med Child Neurol. 2020 Feb 16. doi: 10.1111/dmcn.14490.
    PubMed     Abstract available


  41. WILMSHURST JM
    Treatment of status epilepticus in children: where in the world are we now?
    Dev Med Child Neurol. 2020;62:152.
    PubMed    


    January 2020
  42. FRIEFELD KESSELMAYER R, McMillan T, Lee B, Almane D, et al
    Psychosocial and functional outcomes in young adults with childhood-onset epilepsy: a 10-year follow-up.
    Dev Med Child Neurol. 2020 Jan 27. doi: 10.1111/dmcn.14477.
    PubMed     Abstract available


  43. VARADKAR S
    Epilepsy surgery: more to treatment outcomes than counting seizures.
    Dev Med Child Neurol. 2020 Jan 9. doi: 10.1111/dmcn.14441.
    PubMed    


  44. BOLDYREVA U, Streiner DL, Rosenbaum PL, Ronen GM, et al
    Quality of life in adolescents with epilepsy, cerebral palsy, and population norms.
    Dev Med Child Neurol. 2020 Jan 3. doi: 10.1111/dmcn.14450.
    PubMed     Abstract available


  45. SCHOELER NE
    Potassium citrate supplementation with ketogenic dietary therapy for drug-resistant epilepsy.
    Dev Med Child Neurol. 2020;62:8.
    PubMed    


  46. VOLLMER B
    Severe neonatal hypoxic-ischaemic brain injury: still an important cause of infantile spasms.
    Dev Med Child Neurol. 2020;62:9.
    PubMed    


  47. ABU DHAIS F, McNamara B, O'Mahony O, McSweeney N, et al
    Impact of therapeutic hypothermia on infantile spasms: an observational cohort study.
    Dev Med Child Neurol. 2020;62:62-68.
    PubMed     Abstract available


    December 2019
  48. CHAN SY
    Sleep architecture and homeostasis in children with epilepsy: a neurodevelopmental perspective.
    Dev Med Child Neurol. 2019 Dec 26. doi: 10.1111/dmcn.14437.
    PubMed     Abstract available


  49. GUERRINI R
    Epilepsy of infancy with migrating focal seizures or rigidity and multifocal seizure syndrome, lethal neonatal? Different emphases on a severe phenotype.
    Dev Med Child Neurol. 2019 Dec 26. doi: 10.1111/dmcn.14445.
    PubMed    


  50. SCHEFFER IE, Boysen KE, Schneider AL, Myers CT, et al
    BRAT1 encephalopathy: a recessive cause of epilepsy of infancy with migrating focal seizures.
    Dev Med Child Neurol. 2019 Dec 23. doi: 10.1111/dmcn.14428.
    PubMed     Abstract available


  51. CORBET BURCHER G, Liang H, Lancaster R, Cross JH, et al
    Neuropsychiatric profile of paediatric hypothalamic hamartoma: systematic review and case series.
    Dev Med Child Neurol. 2019;61:1377-1385.
    PubMed     Abstract available


    November 2019
  52. PAPANDREOU A, Danti FR, Spaull R, Leuzzi V, et al
    The expanding spectrum of movement disorders in genetic epilepsies.
    Dev Med Child Neurol. 2019 Nov 29. doi: 10.1111/dmcn.14407.
    PubMed     Abstract available


  53. SALPEKAR JA
    The long view of epilepsy and depression in pediatrics.
    Dev Med Child Neurol. 2019 Nov 25. doi: 10.1111/dmcn.14416.
    PubMed    


  54. COUGHLIN CR 2ND
    Pyridoxine-dependent epilepsy is more than just epilepsy.
    Dev Med Child Neurol. 2019 Nov 25. doi: 10.1111/dmcn.14405.
    PubMed    


  55. BJURULF B, Magnus P, Hallbook T, Stromme P, et al
    Potassium citrate and metabolic acidosis in children with epilepsy on the ketogenic diet: a prospective controlled study.
    Dev Med Child Neurol. 2019 Nov 19. doi: 10.1111/dmcn.14393.
    PubMed     Abstract available


  56. JIAO X, Xue J, Gong P, Wu Y, et al
    Clinical and genetic features in pyridoxine-dependent epilepsy: a Chinese cohort study.
    Dev Med Child Neurol. 2019 Nov 18. doi: 10.1111/dmcn.14385.
    PubMed     Abstract available


  57. SYMONDS JD
    CHD2 epilepsy: epigenetics and the quest for precision medicine.
    Dev Med Child Neurol. 2019 Nov 12. doi: 10.1111/dmcn.14380.
    PubMed    


  58. JAIN P, Smith ML, Speechley K, Ferro M, et al
    Seizure freedom improves health-related quality of life after epilepsy surgery in children.
    Dev Med Child Neurol. 2019 Nov 11. doi: 10.1111/dmcn.14390.
    PubMed     Abstract available


  59. ROSIC T, Avery L, Streiner DL, Ferro MA, et al
    Longitudinal trajectories of depression symptoms in children with epilepsy.
    Dev Med Child Neurol. 2019 Nov 7. doi: 10.1111/dmcn.14387.
    PubMed     Abstract available


  60. CHEN J, Zhang J, Liu A, Zhang L, et al
    CHD2-related epilepsy: novel mutations and new phenotypes.
    Dev Med Child Neurol. 2019 Nov 1. doi: 10.1111/dmcn.14367.
    PubMed     Abstract available


  61. LUX A
    Neurodevelopmental status in infantile spasms and West syndrome: the challenge of assessment.
    Dev Med Child Neurol. 2019;61:1244.
    PubMed    


  62. SUMANASENA SP, Wanigasinghe J, Arambepola C, Sri Ranganathan S, et al
    Developmental profile at initial presentation in children with infantile spasms.
    Dev Med Child Neurol. 2019;61:1295-1301.
    PubMed     Abstract available


    October 2019
  63. CURATOLO P
    Tuberous sclerosis-associated epilepsy and intellectual disability: what role does the mammalian target of rapamycin pathway play?
    Dev Med Child Neurol. 2019 Oct 7. doi: 10.1111/dmcn.14371.
    PubMed    


  64. NABBOUT R, Auvin S, Chiron C, Thiele E, et al
    Perception of impact of Dravet syndrome on children and caregivers in multiple countries: looking beyond seizures.
    Dev Med Child Neurol. 2019;61:1229-1236.
    PubMed     Abstract available


    August 2019
  65. VERHEYEN K, Verbecque E, Ceulemans B, Schoonjans AS, et al
    Motor development in children with Dravet syndrome.
    Dev Med Child Neurol. 2019;61:950-956.
    PubMed     Abstract available


    July 2019
  66. CAYNES K, Rose TA, Theodoros D, Burmester D, et al
    The Functional Communication Classification System: extended reliability and concurrent validity for children with cerebral palsy aged 5 to 18 years.
    Dev Med Child Neurol. 2019;61:805-812.
    PubMed     Abstract available


    June 2019
  67. OH A, Thurman DJ, Kim H
    Independent role of neonatal seizures in subsequent neurological outcomes: a population-based study.
    Dev Med Child Neurol. 2019;61:661-666.
    PubMed     Abstract available


    May 2019
  68. WOOLFENDEN S, Galea C, Smithers-Sheedy H, Blair E, et al
    Impact of social disadvantage on cerebral palsy severity.
    Dev Med Child Neurol. 2019;61:586-592.
    PubMed     Abstract available


    March 2019
  69. RONEN GM, Janssen I
    Patterns of daily activity among young people with epilepsy.
    Dev Med Child Neurol. 2019 Mar 29. doi: 10.1111/dmcn.14223.
    PubMed     Abstract available


  70. TSUBOUCHI Y, Tanabe A, Saito Y, Noma H, et al
    Long-term prognosis of epilepsy in patients with cerebral palsy.
    Dev Med Child Neurol. 2019 Mar 10. doi: 10.1111/dmcn.14188.
    PubMed     Abstract available


  71. MCTAGUE A
    Navigating the genetic landscape of childhood epilepsy: a new perspective?
    Dev Med Child Neurol. 2019 Mar 10. doi: 10.1111/dmcn.14203.
    PubMed    


    February 2019
  72. SPAGNOLI C, Pisani F
    The independent role of neonatal seizures in epilepsy and other long-term neurological outcomes.
    Dev Med Child Neurol. 2019 Feb 14. doi: 10.1111/dmcn.14197.
    PubMed    


  73. SENTENAC M, Lach LM, Gariepy G, Elgar FJ, et al
    Education disparities in young people with and without neurodisabilities.
    Dev Med Child Neurol. 2019;61:226-231.
    PubMed     Abstract available


    January 2019
  74. GATAULLINA S, Bienvenu T, Nabbout R, Huberfeld G, et al
    Gene mutations in paediatric epilepsies cause NMDA-pathy, and phasic and tonic GABA-pathy.
    Dev Med Child Neurol. 2019 Jan 25. doi: 10.1111/dmcn.14152.
    PubMed     Abstract available


  75. GILL D
    Dealing with a first seizure: accurate diagnosis and good management.
    Dev Med Child Neurol. 2019;61:9-10.
    PubMed    


    November 2018
  76. ALI S, Scheffer IE, Sadleir LG
    Efficacy of cannabinoids in paediatric epilepsy.
    Dev Med Child Neurol. 2018 Nov 6. doi: 10.1111/dmcn.14087.
    PubMed     Abstract available


    September 2018
  77. SARTORI S, Nosadini M, Tessarin G, Boniver C, et al
    First-ever convulsive seizures in children presenting to the emergency department: risk factors for seizure recurrence and diagnosis of epilepsy.
    Dev Med Child Neurol. 2018 Sep 7. doi: 10.1111/dmcn.14015.
    PubMed     Abstract available


    August 2018
  78. CORTES-SALADELAFONT E, Molero-Luis M, Cuadras D, Casado M, et al
    Gamma-aminobutyric acid levels in cerebrospinal fluid in neuropaediatric disorders.
    Dev Med Child Neurol. 2018;60:780-792.
    PubMed     Abstract available


    July 2018
  79. DAN B
    Vagal nerve stimulation beyond epilepsy.
    Dev Med Child Neurol. 2018;60:634.
    PubMed    


    June 2018
  80. KIRSCH AC, Zaccariello MJ
    Global development and adaptive functioning in children with epilepsy.
    Dev Med Child Neurol. 2018 Jun 21. doi: 10.1111/dmcn.13941.
    PubMed    


  81. REILLY C, Atkinson P, Memon A, Jones C, et al
    Global development and adaptive behaviour in children with early-onset epilepsy: a population-based case-control study.
    Dev Med Child Neurol. 2018 Jun 3. doi: 10.1111/dmcn.13926.
    PubMed     Abstract available


  82. CHIRON C
    Long-term pragmatic use of stiripentol for Dravet syndrome.
    Dev Med Child Neurol. 2018;60:535.
    PubMed    


  83. MYERS KA, Lightfoot P, Patil SG, Cross JH, et al
    Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study.
    Dev Med Child Neurol. 2018;60:574-578.
    PubMed     Abstract available


    April 2018
  84. DRAVET C
    Acute encephalopathy after febrile status epilepticus: an underdiagnosed, misunderstood complication of Dravet syndrome.
    Dev Med Child Neurol. 2018 Apr 14. doi: 10.1111/dmcn.13778.
    PubMed    


  85. WRIGHT I
    Paediatric convulsive status epilepticus, epilepsy, and behavioural outcomes.
    Dev Med Child Neurol. 2018;60:338-339.
    PubMed    


  86. AUVIN S
    A common language of seizures and epilepsies: International League Against Epilepsy 2017 classifications.
    Dev Med Child Neurol. 2018;60:329.
    PubMed    


    March 2018
  87. TIAN X, Ye J, Zeng Q, Zhang J, et al
    The clinical outcome and neuroimaging of acute encephalopathy after status epilepticus in Dravet syndrome.
    Dev Med Child Neurol. 2018 Mar 24. doi: 10.1111/dmcn.13727.
    PubMed     Abstract available


  88. VEGA C, Sanchez Fernandez I, Peters J, Thome-Souza MS, et al
    Response to clobazam in continuous spike-wave during sleep.
    Dev Med Child Neurol. 2018;60:283-289.
    PubMed     Abstract available


    February 2018
  89. VILLALUZ MM, Lomax LB, Jadhav T, Cross JH, et al
    The ketogenic diet is effective for refractory epilepsy associated with acquired structural epileptic encephalopathy.
    Dev Med Child Neurol. 2018 Feb 16. doi: 10.1111/dmcn.13687.
    PubMed     Abstract available


  90. ZUBERI SM
    Sleep, oxygen saturation, and seizures in Dravet syndrome.
    Dev Med Child Neurol. 2018;60:118.
    PubMed    


  91. LICHENI SH, Mcmahon JM, Schneider AL, Davey MJ, et al
    Sleep problems in Dravet syndrome: a modifiable comorbidity.
    Dev Med Child Neurol. 2018;60:192-198.
    PubMed     Abstract available


    January 2018
  92. LAGAE L, Brambilla I, Mingorance A, Gibson E, et al
    Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey.
    Dev Med Child Neurol. 2018;60:63-72.
    PubMed     Abstract available


    December 2017
  93. VARADKAR S
    Continuous spike-wave during sleep: treating an epilepsy without seizures.
    Dev Med Child Neurol. 2017 Dec 28. doi: 10.1111/dmcn.13650.
    PubMed    


  94. ROULET-PEREZ E, Mayor C
    Childhood epilepsy with centro-temporal spikes (rolandic epilepsy) and written language.
    Dev Med Child Neurol. 2017 Dec 21. doi: 10.1111/dmcn.13658.
    PubMed    


  95. CURRIE NK, Lew AR, Palmer TM, Basu H, et al
    Reading comprehension difficulties in children with rolandic epilepsy.
    Dev Med Child Neurol. 2017 Dec 14. doi: 10.1111/dmcn.13628.
    PubMed     Abstract available


  96. MARTINOS MM, Pujar S, Gillberg C, Cortina-Borja M, et al
    Long-term behavioural outcomes after paediatric convulsive status epilepticus: a population-based cohort study.
    Dev Med Child Neurol. 2017 Dec 10. doi: 10.1111/dmcn.13636.
    PubMed     Abstract available


  97. RYDENHAG B
    Long-term effects of corpus callosotomy for therapy-resistant epileptic seizures.
    Dev Med Child Neurol. 2017 Dec 1. doi: 10.1111/dmcn.13639.
    PubMed    


    November 2017
  98. TRIVISANO M, Specchio N
    Focal cortical dysplasia in genetic epilepsy: new insights from PCDH19-related epilepsy.
    Dev Med Child Neurol. 2017 Nov 14. doi: 10.1111/dmcn.13615.
    PubMed    


  99. GATAULLINA S, Dulac O
    Is epilepsy the cause of comorbidities in Dravet syndrome?
    Dev Med Child Neurol. 2017 Nov 10. doi: 10.1111/dmcn.13613.
    PubMed    


  100. STRASSER L, Downes M, Kung J, Cross JH, et al
    Prevalence and risk factors for autism spectrum disorder in epilepsy: a systematic review and meta-analysis.
    Dev Med Child Neurol. 2017 Nov 9. doi: 10.1111/dmcn.13598.
    PubMed     Abstract available


    October 2017
  101. KURIAN M, Korff CM, Ranza E, Bernasconi A, et al
    Focal cortical malformations in children with early infantile epilepsy and PCDH19 mutations: case report.
    Dev Med Child Neurol. 2017 Oct 24. doi: 10.1111/dmcn.13595.
    PubMed     Abstract available


  102. VOLLEBREGT AAM, Hoogeveen-Westerveld M, Kroos MA, Oussoren E, et al
    Genotype-phenotype relationship in mucopolysaccharidosis II: predictive power of IDS variants for the neuronopathic phenotype.
    Dev Med Child Neurol. 2017;59:1063-1070.
    PubMed     Abstract available


    September 2017
  103. PILLI VK, Behen ME, Hu J, Xuan Y, et al
    Clinical and metabolic correlates of cerebral calcifications in Sturge-Weber syndrome.
    Dev Med Child Neurol. 2017;59:952-958.
    PubMed     Abstract available


    July 2017
  104. DELOBEL-AYOUB M, Klapouszczak D, van Bakel MME, Horridge K, et al
    Prevalence and characteristics of autism spectrum disorders in children with cerebral palsy.
    Dev Med Child Neurol. 2017;59:738-742.
    PubMed     Abstract available


    June 2017
  105. DOWNS J, Leonard H, Wong K, Newton N, et al
    Quantification of walking-based physical activity and sedentary time in individuals with Rett syndrome.
    Dev Med Child Neurol. 2017;59:605-611.
    PubMed     Abstract available


  106. AMIN S, Lux A, Calder N, Laugharne M, et al
    Causes of mortality in individuals with tuberous sclerosis complex.
    Dev Med Child Neurol. 2017;59:612-617.
    PubMed     Abstract available


    January 2017
  107. DAN B
    Gap junctions in epilepsy: for better or worse.
    Dev Med Child Neurol. 2017;59:4.
    PubMed    


    June 2016
  108. HORRIDGE KA, Mcgarry K, Williams J, Whitlingum G, et al
    Prospective pilots of routine data capture by paediatricians in clinics and validation of the Disabilities Complexity Scale.
    Dev Med Child Neurol. 2016;58:581-8.
    PubMed     Abstract available


  109. HORRIDGE KA, Harvey C, McGarry K, Williams J, et al
    Quantifying multifaceted needs captured at the point of care. Development of a Disabilities Terminology Set and Disabilities Complexity Scale.
    Dev Med Child Neurol. 2016;58:570-80.
    PubMed     Abstract available


  110. TANTSIS EM, Gill D, Griffiths L, Gupta S, et al
    Eye movement disorders are an early manifestation of CACNA1A mutations in children.
    Dev Med Child Neurol. 2016;58:639-44.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: